BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
Phase II trial begins of CAL-101/rituximab combination in CLL
Oct. 21, 2010
Plexxikon presents new inhibitors of protein kinases
Oct. 21, 2010
EC grants orphan drug status for eflornithine in familial adenomatous polyposis
Oct. 21, 2010
EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis
Oct. 20, 2010
Pathway Therapeutics presents new inhibitors of PI3K isoforms
Oct. 20, 2010
EMA recommends approval of CTI's pediatric investigation plan for Pixuvri
Oct. 20, 2010
New selective serine/threonine-protein kinase 6 inhibitors discovered
Oct. 19, 2010
EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia
Oct. 19, 2010
New inhibitors of dual specificity protein kinase TTK claimed
Oct. 19, 2010
New protein kinase inhibitors identified by sanofi-aventis
Oct. 19, 2010
Previous
1
2
…
2625
2626
2627
2628
2629
2630
2631
2632
2633
…
4151
4152
Next
RSS